Akorn - 16 Year Stock Split History | AKRX

Stock split history for Akorn since 2002. Prices shown are actual historical values and are not adjusted for either splits or dividends. Please see the "Historical Prices" tab for adjusted price values.
Akorn Annual Stock Splits
Akorn Quarterly Stock Splits
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.842B $0.841B
Akorn, Inc. is a specialty generic pharmaceutical company engaged in the development, manufacture and marketing of multisource and branded pharmaceuticals. They specialize in difficult-to-manufacture sterile and non-sterile dosage forms including: ophthalmics, injectables, oral liquids, otics, topicals, inhalants, and nasal sprays. Akorn markets its products to retail pharmacies, ophthalmologists, optometrists, physicians, veterinarians, hospitals, clinics, wholesalers, distributors, group purchasing organizations, and government agencies. Their strategy is focused on continuing to strengthen our leadership position in the development and marketing of specialized generic and branded pharmaceuticals, over-the-counter (`OTC`) drug products and animal health products.
Stock Name Country Market Cap PE Ratio
Allergan (AGN) Ireland $63.812B 10.95
Teva Pharmaceutical Industries (TEVA) Israel $22.636B 6.32
Mylan (MYL) United Kingdom $17.070B 7.26
Bausch Health Cos (BHC) Canada $9.063B 6.75
Dr Reddy's Laboratories (RDY) India $5.840B 26.09
Supernus Pharmaceuticals (SUPN) United States $2.522B 26.99
Mallinckrodt Public (MNK) United Kingdom $2.316B 3.94
Amphastar Pharmaceuticals (AMPH) United States $0.862B 124.20
Homology Medicines (FIXX) United States $0.751B 0.00
CymaBay Therapeutics (CBAY) United States $0.654B 0.00
Assembly Biosciences (ASMB) United States $0.652B 0.00
Voyager Therapeutics (VYGR) United States $0.519B 0.00
Adamas Pharmaceuticals (ADMS) United States $0.517B 0.00
Progenics Pharmaceuticals (PGNX) United States $0.475B 0.00
Corium (CORI) United States $0.456B 0.00
Teligent (TLGT) United States $0.179B 0.00
Zynerba Pharmaceuticals (ZYNE) United States $0.133B 0.00
Sol-Gel Technologies (SLGL) Israel $0.125B 0.00
Aevi Genomic Medicine (GNMX) United States $0.069B 0.00
Aquinox Pharmaceuticals (AQXP) Canada $0.062B 0.00
Evoke Pharma (EVOK) United States $0.045B 0.00
Acasti Pharma (ACST) Canada $0.044B 0.00
Agile Therapeutics (AGRX) United States $0.034B 0.00
Pernix Therapeutics Holdings (PTX) United States $0.011B 0.00
China Pharma Holdings (CPHI) China $0.011B 0.00